MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma.
Jenny J LiXiaoling ZhangNeil SankarLynn EspirituSanjeev RedkarGuo-Liang YuSani H KizilbashPublished in: JCO precision oncology (2022)